SWPONL sponsors gain unique access to some of the area's top nurse leaders. Our members and the conference
attendees are nurses holding a variety of healthcare leadership positions. They represent healthcare facilities and
academic institutions throughout Southwestern Pennsylvania and the surrounding areas. They are typically responsible
for overseeing staff nurses or other nurse leaders and hold titles such as Chief Nursing Officer, VP of Patient
Services, Chief Clinical Officer, Service Line Directors.
MEET THE 2024 SPONSORS
For over 80 years, the Duquesne University School of Nursing has been recognized as a pioneer in nursing education and as one of the nation’s foremost nursing schools. The school continues to be defined by its strategic leadership and innovative programming. Evidence-based nursing, critical thinking and intellectual curiosity go hand-in-hand with ethical practice, community service and a commitment to social justice. Our goal is to ensure that our students exemplify the highest levels of competency, compassion and ethical behavior. Our current programs include the BSN, MSN, post-master’s certificates, PhD, DNP, and DNAP.
Applied Medical Technology, Inc. (AMT) is a global leader in the development, design, and manufacture of enteral feeding devices, accessories, and surgical products. We are honored to serve the global community as we continue to introduce innovative products and materials, designed to increase patient comfort while improving patient outcomes.
ICU Medical is a global leader offering clinically essential products and solutions that connect patients with caregivers through life-enhancing, innovative technology and services that provide meaningful clinical value. Our robust portfolio features medical delivery systems and consumable products for infusion therapy, emergency medicine, general and regional anesthesia, homecare, NICU/PICU, oncology, pain management, and respiratory care. We are a dedicated partner delivering leading-edge products across the continuum of care.
Considered the founder of the industry, Genentech, now a member of the Roche Group, has been delivering on the promise of biotechnology for more than 45 years. Genentech is a biotechnology company dedicated to pursuing groundbreaking science to discover and develop medicines for people with serious and life-threatening diseases. Our transformational discoveries include the first targeted antibody for cancer and the first medicine for primary progressive multiple sclerosis. We celebrate our unique history as the pioneers of scientific breakthroughs that have an incredible track record of improving lives. And yet, our ambitions are bigger and bolder. Together, we are united in a bold quest to solve the world’s most complex health challenges and serve society.